Quartile 1 (Q1) represents the quartile with the lowest values of fasting hs-GH.
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Methods
At the baseline examination blood pressure was measured with a mercury-column sphygmomanometer after 10 minutes rest in the supine position. Waist circumference was measured at the level of the umbilicus. Current cigarette smoking was defined as any use within the last year, and was surveyed through a self-administered questionnaire. The same questionnaire in combination with a diary was used to record prevalence of anti-hypertensive medication at baseline. Diseases, 9 th and 10 th revisions (ICD-9 and ICD-10) codes 410 and I21 respectively in the SHDR or SCDR, codes 412 and 414 (ICD-9) or I22, I23 and I25 (ICD-10) of the SCDR. Coronary artery bypass graft surgery (CABG) was identified from national classification of surgical procedures, KKÅ from 1963 until 1989 and Op6 since then. CABG was defined as a procedure code of 3065, 3066, 3068, 3080, 3092, 3105, 3127, 3158 (Op6) or FN (KKÅ97). PCI was defined based on the operation codes FNG05 and FNG02. Heart failure was defined using diagnosis codes 428
CAD was defined on the basis of International Classification of
(ICD-9) and I50 and I11.0 (ICD-10) as primary diagnosis in the SHDR and SCDR. Stroke was defined on the basis of codes 430, 431, or I60, I61, I63 and I64
(ICD-10). Cardiovascular mortality was defined on the basis of (ICD-9) codes 390-459 or (ICD-10) codes I00-I99 in the SCDR.
The following section describes the development of the hs-GH assay. Mouse monoclonal antibodies were raised against GH (NIBSC code 98/574, National Institute for Biological Standards and Control, Herfordshire, UK) (Sphingotec GmbH, Borgsdorf, Germany). The assay was set up as follows: 100 µg of tracer antibody was labeled with 10 µg Acridinium NHS-ester (InVent GmbH, Hennigsdorf, Germany). Labeled antibody was purified by gelfiltration HPLC on Bio-Sil SEC 400-5 (Bio-Rad Laboratories, Inc., USA). The purified labelled antibody was diluted in (300 mmol/l potassiumphosphate, 100 mmol/l NaCl, 10 mmol/l Na-EDTA, 5 g/l bovine serum albumin, pH 7.0). The final concentration was approx. Table S8 : Improvement of discrimination (C-statistics) and reclassification of 10-year risk estimates (category-free Net Reclassification Improvement (NRI (>0))) for addition of growth hormone to the Framingham model of 10-year hard coronary heart disease. 
NRI (>0) † C-statistics
